Company intelligence / Profile preview

Auven Therapeutics

St. Thomas, United States Virgin Islandsauventx.com ↗
Ownership
Private
Employees
~200
Development stage
Other
01

Overview

Auven Therapeutics operates as a private equity firm focused on life sciences, investing in and managing drug development programs through its internal capabilities. It bridges funding gaps for small biotech firms and advances assets toward later-stage development or exit. The company has made at least 12 investments with several successful exits. Clinical results are tied to its portfolio companies rather than direct proprietary programs.

Modalities
Small molecules and biologic drugs
Industry
Investors
02

Partnerships

Bellus Health partnership announced May 2014

Beyond the preview

Go deeper on Auven Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auven Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call